Conclusion Our study suggests that among older adults with type 2 diabetes treated with levothyroxine, initiation and continued use of GLP-1RA was associated with an increased risk of atrial fibrillation or flutter compared to SGLT2 inhibitors, without an elevation on stroke risk
However, real-world data show that fewer patients reach the maximum tirzepatide dose compared to semaglutide, which may impact effectiveness outside of clinical trials
But what exactly are they
The smallest amount can trigger an immune response, and some experts believe the response can last weeks to months
These innovative treatments, which mimic natural hormones in the body, have revolutionized how we approach chronic weight management and Type 2 diabetes
However, weight loss on phentermine is usually reported after 12 weeks of treatment